Timeline

2020

  • Build mycology & neuroscience teams

  • In discussion with contracted labs

  • $500,000 financing

  • Procure unique mushroom strains

  • Lab space and growing facility search

2021 Q1

  • $5,000,000 financing

  • Contracted lab commences  production

  • Develop clinical trial programs

  • Initiate AB facility build

  • Begin CDSA license application

2021 Q2

  • Develop e-Clinic study program

  • Completion of research on unique mushroom strain

  • Finalize initial research agreements with universities

2021 Q3

  • Completion of growing and lab space

  • Produce non-psilocybin mushrooms to verify growing technique

  • Launch PR branding campaign

  • Start e-Clinic studies

2021 Q4

  • Receive CDSA Dealer’s License

  • Harvest initial crop psilocybin producing mushrooms

  • Begin IP process for proven unique growing techniques

2022

  • IP for patented clinical formulations

  • Revenue from AB production realized

  • First results from clinical trials

2023

  • Initiate construction on second facility

  • Inaugural sales into foreign markets

  • Launch new products

  • Further clinical study results